Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference


Werte in diesem Artikel
Aktien

91.50 EUR 0.00 EUR 0.0 %

BOSTON, Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time.

The public may access Mr. Simon's presentation live via audio webcast at:

https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true 

The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:                                              


Olga Guyette, Vice President-Investor Relations & Treasury     

David Trenk, Manager-Investor Relations

(781) 356-9763                                                                         

(203) 733-4987

olga.guyette@haemonetics.com                                           

david.trenk@haemonetics.com                                                                                



Media Contact:                                                           


Josh Gitelson, Sr. Director-Global Communications       


(781) 356-9776


josh.gitelson@haemonetics.com 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html

SOURCE Haemonetics Corporation

Aktuelle Haemonetics Aktie News

Werbung

Haemonetics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
07.08.19 Haemonetics Outperform Barrington Research
08.05.19 Haemonetics Outperform Barrington Research
09.08.18 Haemonetics Outperform Barrington Research
07.02.18 Haemonetics Outperform Barrington Research
08.11.17 Haemonetics Outperform Barrington Research

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.